Abstract
Ischemia and reperfusion injury is of critical importance for organ survival and function in liver transplantation. It induces apoptosis which is executed by caspases. Futhermore, apoptosis may be regulated by the rheostat of pro- and anti-apoptotic proteins of the bcl-2 family. Bcl-2 levels can be influenced by caspase 3 inhibition. Aim of this study was to investigate the effect of an irreversible inhibitor of caspase 3 on early graft function, survival and hepatic bcl-2 expression after liver transplantation. Lewis rats underwent syngenic, orthotopic liver transplantation with arterial reconstruction following 16 hours graft storage in UW (4°C). Donor animals and grafts (preservation and flush solution) were treated with the caspase 3 inhibitor Z-DEVD-FMK. Animals treated either with a control protein (Z-FA-FMK) without inhibitory function, with the vehicle (DMSO/PBS) or animals transplanted without specific treatment served as controls. Survival was determined at 7 days after surgery, which was considered definite. As an indicator for early graft function, bile flow was measured during 100 min. following graft reperfusion. Liver tissue specimen were collected after 100 min. and after 7 days. TUNEL staining served for quantification of apoptotic cells. Bcl-2 and bcl-xL protein levels as well as caspase 3 expression were assessed by Western blot technique. Statistics were calculated by ANOVA and Kaplan-Meier/log-rank analysis. TUNEL staining revealed a significant reduction of apoptotic endothelial cells per high power field after caspase 3 inhibition as compared to controls. Survival after caspase inhibition was significantly improved in comparison to all control groups. Interestingly, this was not associated with enhanced bile production in the early postreperfusion phase indicating that early graft function was not altered. Bcl-2 protein levels were increased in the Z-DEVD-FMK group after 7 days. Caspase 3 inhibition therefore seems to be a potent therapeutical access for improvement of survival after ischemia and reperfusion injury in liver grafts. Besides inhibition of caspases this effect might be mediated by higher bcl-2 in the grafts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Rentsch M, Beham A, Iesalnieks I, Mirwald T, Anthuber M, Jauch KW (2001) Impact of prolonged cold ischemia and reperfusion on apoptosis, activation of caspase 3, and expression of bax after liver transplantation in the rat. Transplant Proc 33(1-2): 850–851
Gao W, Bentley RC, Madden JF, Clavien PA (1998) Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 27: 1652–1660
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik VA (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43
Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4: 327–332
Grunenfelder J, Miniati DN, Murata S, Falk V, Hoyt EG, Kown M, Koransky ML, Robbins RC (2001) Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation 104(12 Suppl 1): 1202–1206
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Müller, T.H.J. et al. (2003). Irreversible Caspase-3-Inhibition verringert Apoptose und verbessert das Überleben nach Lebertransplantation an der Ratte. In: Menger, M.D., Haas, N.P., Neugebauer, E., Bauer, H. (eds) Chirurgisches Forum 2003 für experimentelle und klinische Forschung. Deutsche Gesellschaft für Chirurgie, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19024-7_115
Download citation
DOI: https://doi.org/10.1007/978-3-642-19024-7_115
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00659-6
Online ISBN: 978-3-642-19024-7
eBook Packages: Springer Book Archive